33
7.
Schiffmann R, Kopp JB, Austin HA, III, Sabnis S, Moore DF,
Weibel T, Balow JE, Brady RO. Enzyme replacement therapy in
Fabry disease: a randomized controlled trial. JAMA 285(21):
2743-2749, 6/2001.
Fibromyalgia
1.
Armstrong DG, Chappell AS, Le TK, Kajdasz DK, Backonja M,
D'Souza DN, Russell JM. Duloxetine for the management of
diabetic peripheral neuropathic pain: evaluation of
functional outcomes. Pain Med 8(5): 410-418, 7/2007.
2.
Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar
S, Goldstein DJ. A double-blind, multicenter trial comparing
duloxetine with placebo in the treatment of fibromyalgia
patients with or without major depressive disorder. Arthritis
Rheum 50(9): 2974-2984, 9/2004.
3.
Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ,
Iyengar S, Wernicke JF. A randomized, double-blind, placebo-
controlled trial of duloxetine in the treatment of women with
fibromyalgia with or without major depressive disorder. Pain
119(1-3): 5-15, 12/2005.
4.
Arnold LM, Pritchett YL, D'Souza DN, Kajdasz DK, Iyengar S,
Wernicke JF. Duloxetine for the treatment of fibromyalgia in
women: pooled results from two randomized, placebo-
controlled clinical trials. J Womens Health (Larchmt ) 16(8):
1145-1156, 10/2007.
5.
Arnold LM, Goldenberg DL, Stanford SB, Lalonde JK, Sandhu
HS, Keck PE, Welge JA, Bishop F, Stanford KE, Hess EV, Hudson
JI. Gabapentin in the treatment of fibromyalgia - A
randomized, double-blind, placebo-controlled, multicenter
trial. Arthritis and Rheumatism 56(4): 1336-1344, 4/2007.
6.
Dungey J, Arnold L, Pritchett Y, Robinson M, D'Souza D,
Wernicke J. PR_186: Duloxetine in the Treatment of
Fibromyalgia in Women: Results From 2 Clinical Trials. Archives
of Physical Medicine and Rehabilitation 87(11): e36, 11/2006.
7.
Russell IJ, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM,
Detke MJ, Walker DJ, Chappell AS, Arnold LM. Efficacy and
34
safety of duloxetine for treatment of fibromyalgia in patients
with or without major depressive disorder: Results from a 6-
month, randomized, double-blind, placebo-controlled, fixed-
dose trial. Pain 136(3): 432-444, 6/2008.
8.
Rutledge DN, Jones CJ. Effects of topical essential oil on
exercise volume after a 12-week exercise program for women
with fibromyalgia: A pilot study. Journal of Alternative and
Complementary Medicine 13(10): 1099-1106, 12/2007.
HIV/AIDS
1.
Breitbart W, McDonald MV, Rosenfeld B, Passik SD, Hewitt D,
Thaler H, Portenoy RK. Pain in ambulatory AIDS patients. I: Pain
characteristics and medical correlates. Pain 68(2-3): 315-321,
12/1996.
2.
Breitbart W, Rosenfeld BD, Passik SD, McDonald MV, Thaler H,
Portenoy RK. The undertreatment of pain in ambulatory AIDS
patients. Pain 65(2-3): 243-249, 5/1996.
3.
Breitbart W, Rosenfeld B, Passik S, Kaim M, Funesti-Esch J, Stein
K. A comparison of pain report and adequacy of analgesic
therapy in ambulatory AIDS patients with and without a history
of substance abuse. Pain 72(1-2): 235-243, 8/1997.
4.
Breitbart W, Passik S, McDonald MV, Rosenfeld B, Smith M,
Kaim M, Funesti-Esch J. Patient-related barriers to pain
management in ambulatory AIDS patients. Pain 76(1-2): 9-16,
5/1998.
5.
Griswold GA, Evans S, Spielman L, Fishman B. Coping
strategies of HIV patients with peripheral neuropathy. AIDS
Care 17(6): 711-720, 8/2005.
6.
Hoyt MJ, Nokes K, Newshan G, Staats JA, Thorn M. The effect
of chemical dependency on pain perception in persons with
AIDS. J Assoc Nurses AIDS Care 5(3): 33-38, 5/1994.
7.
Larue F, Fontaine A, Colleau SM. Underestimation and
undertreatment of pain in HIV disease: multicentre study. BMJ
314(7073): 23-28, 1/1997.
